吕文良从“毒、瘀、虚”论治慢性乙型病毒性肝炎
LYU Wenliang's Treatment of Chronic Viral Hepatitis B from "Toxin, Blood Stasis and Deficiency"
DOI:10.13192/j.issn.1000-1719.2021.05.012
扫 描 看 全 文
1.中国中医科学院广安门医院感染疾病科,北京 100053
扫 描 看 全 文
刘爽, 陈静, 赵鑫, 等. 吕文良从“毒、瘀、虚”论治慢性乙型病毒性肝炎[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.05.012
LIU Shuang, CHEN Jing, ZHAO Xin, et al. LYU Wenliang's Treatment of Chronic Viral Hepatitis B from "Toxin, Blood Stasis and Deficiency"[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.05.012
刘爽, 陈静, 赵鑫, 等. 吕文良从“毒、瘀、虚”论治慢性乙型病毒性肝炎[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.05.012 DOI:
LIU Shuang, CHEN Jing, ZHAO Xin, et al. LYU Wenliang's Treatment of Chronic Viral Hepatitis B from "Toxin, Blood Stasis and Deficiency"[DB/OL].(2023-09-15)[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.13192/j.issn.1000-1719.2021.05.012 DOI:
吕文良教授认为,慢性乙型病毒性肝炎之病机不外于“毒”“瘀”“虚”此三种病理因素。因此在临证治疗时,常以此为基,一者注重扶正固本,并擅用生黄芪、炒白术、山药、白芍、生地黄、女贞子、墨旱莲等中药,通过健脾益气,滋养肝肾,以制肝脾肾之虚;二者注重攻毒解机,并擅用焦山楂、焦神曲、焦麦芽、黄芩、黄连、黄柏、茵陈、熊胆粉等中药,通过清热利湿,祛痰清浊,消食导滞,以肃机体胶结之毒;三者注重化瘀荡积,并擅用生山楂、川芎、乳香、没药、郁金、益母草、醋延胡索、红景天、三棱、莪术、水蛭、王不留行等中药,通过活血通络,软坚散结,以除积旧之顽疴。是以,正气得复,则机体健运如常;邪毒得除,则机体无侵扰之忧;瘀浊得清,则机体无闭阻之扰。故该文即从“毒”“瘀”“虚”此三方面,就吕文良教授治疗慢性乙型病毒性肝炎的特色进行总结,以浅述其学术经验。
Professor LYU Wenliang believes that the pathogenesis of chronic viral hepatitis B is nothing more than three pathological factors, which are toxin, blood stasis and deficiency. Therefore, the treatment in clinic is often based on this. The first is to attach importance to strengthening the vital energy, and is adapt at using traditional Chinese medicines such as Huangqi (Radix Astragali), Baizhu (Radix Atractylodis Macrocephalae), Shanyao (Yam), Baishao (Radix Paeoniae Alba), Shengdihuang (Radix Rehmanniae), Nuzhenzi (Fructus Ligustri Lucidum) and Mohanlian (Eclipta alba), to invigorate spleen and Qi and nourish liver and kidney, in order to control the deficiency of liver, spleen and kidney. The second is to pay attention to attacking the toxin and relieving the stagnation, and is adapt at using traditional Chinese medicines such as Jiaoshanzha (Crataegi Fructus), Jiaoshenqu (Massa Medicata Fermentata), Jiaomaiya (Hordei Fructus Germinatus), Huangqin (Radix Scutellariae), Huanglian (Rhizoma Coptidis), Huangbai (Cortex Phellodendri), Yinchen (Artemisia capillaris) and Xiongdan (bear bile) powder, to clear away heat and dampness, eliminate phlegm and clear away turbidity, eliminate food stagnation and purge the toxin. The third is to resolve blood stasis and eliminate the mass, and is adapt at using Shanzha (Crataegi Fructus), Chuanxiong (Chuanxiong Rhizoma), Ruxiang (Olibanum), Moyao (Myrrha), Yujin (Curcumae Radix), Yimucao (Leonuri Herba), Yanhusuo (Corydalis Rhizoma), Hongjingtian (Rhodiolae Crenulatae Radix Et Rhizoma), Sanleng (Sparganii Rhizoma), Ezhu (Curcumae Rhizoma), Shuizhi (Hirudo) and Wangbuliuxing (Vaccariae Semen), to activate blood circulation and dredge collaterals and soften and disperse the mass. The righteousness is restored, and then the body is as usual. The evil toxin is removed, and then the body has no worries of infestation. The blood stasis is clear, and then the body has no closed disturbance. Therefore, this article summarized the characteristics of Professor LYU Wenliang's treatment of chronic viral hepatitis B from toxin, blood stasis and deficiency and briefly described his academic experience.
慢性乙型病毒性肝炎毒瘀虚
chronic hepatitis Btoxinblood stasisdeficiency
王贵强, 王福生, 庄辉, 等. 慢性乙型肝炎防治指南(2019年版)[J]. 临床肝胆病杂志, 2019, 35(12): 2648-2669.
张若宣, 吕文良, 曹正民, 等. 姚乃礼以“肝络”理论辨治慢性乙型病毒性肝炎肝纤维化[J]. 中医学报, 2020, 35(2): 1-4.
中华中医药学会肝胆病专业委员会, 中国民族医药学会肝病专业委员会. 慢性乙型肝炎中医诊疗指南(2018年版)[J]. 中西医结合肝病杂志, 2019, 29(1): 97-102.
胡伶姿, 吕文良, 周文慧, 等. 玉屏风散防治肝病的研究进展[J]. 世界中医药, 2018, 13(9): 2357-2361.
汪昂. 本草求真[M]. 北京: 人民卫生出版社, 2018: 3.
孙星琰. 神农本草经[M]. 南京: 江苏凤凰美术出版社, 2017: 7.
张德裕. 本草正义[M]. 北京: 中国中医药出版社, 2015: 1.
汪昂. 本草备要[M]. 北京: 人民卫生出版社, 2018: 3.
李时珍. 本草纲目[M]. 北京: 北京燕山出版社, 2009: 11.
吕畅. 山楂不同炮制品对高脂膳食诱导肥胖大鼠的预防作用研究[D]. 济南: 山东大学, 2019.
王永涛, 张怀亮. 当归六黄汤临床新用医案3则[J]. 新中医, 2019, 51(7): 106-107.
张锡纯. 医学衷中参西录[M]. 北京: 人民卫生出版社, 2006: 7.
韩莹, 孙晖, 邱丽萍, 等. 熊胆药用特殊价值及其药效物质基础研究[J]. 中医药信息, 2020, 37(1): 12-18.
吴成. 熊胆粉治疗肝胆系统疾病的研究概述[J]. 中国民族民间医药, 2018, 27(5): 55-59.
阳国彬. 基于数据挖掘的原发性肝癌辨治规律研究[D]. 武汉: 湖北中医药大学, 2019.
吕运权, 张恒. 川芎和郁金防治冠心病的研究进展[J]. 中西医结合心脑血管病杂志, 2019, 17(7): 1011-1013.
曹磊, 平芬, 韩书芝, 等. 大株红景天在不同系统疾病中的应用进展[J]. 河北医药, 2020, 42(4): 608-612.
李集正, 卢玉平. 大株红景天治疗不稳定型心绞痛患者的疗效及对hs-CRP、血脂、血液流变学指标的影响[J]. 云南中医中药杂志, 2020, 41(1): 40-43.
顾成娟, 朴春丽, 吴学敏, 等. 降香、水蛭、川芎治疗微循环障碍经验——仝小林三味小方撷萃[J]. 吉林中医药, 2019, 39(11): 1466-1468.
魏薇. 中药王不留行的研究进展[J]. 中国医药指南, 2014, 12(16): 87-88.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构